Vertera Spine received FDA clearance for its COALESCE porous PEEK Lumbar Interbody Fusion Device.
Spinal Tech
The global neurosurgery market will likely grow at a compound annual growth rate of 9.42 percent through 2020, according to a Market Reports World analysis.
The global bone growth stimulator market will likely grow at a compound annual growth rate of 8.5 percent through 2025, according to a Research and Markets report.
Axerion Therapeutics rebranded as ReNetX Bio.
Tissue Regenix reported a proposed acquisition of CellRight Technologies.
Advertisement
Here are 12 key notes on orthopedic and spine device companies from the past week.
The global vertebroplasty and kyphoplasty market will expand, according to a Transparency Market Research report.
The global spinal cord stimulation market will grow at a compound annual growth rate of 9.2 percent through 2021, based on a Market Data Forecast report, according to medGadget.
According to Market Realist, Stryker saw an 18.5 percent year over year growth in the first quarter of 2017. The company is now looking to expand its interventional spine segment.
Premia Spine launched an FDA pivotal study of the TOPS system, and the first procedure was performed in Pennsylvania.